Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission
Microbiology Spectrum · 2023
DOI: 10.1128/spectrum.00653-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Chengjin Ye und 13 weiteren Autor:innen. Beteiligte Einrichtung: Disease Intervention and Prevention, and Population Health Programs, Texas Biomedical Research Institute, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Live-attenuated vaccines (LAVs) are able to induce robust immune responses, including both humoral and cellular immunity, representing a very promising option to provide broad and long-term immunity. To develop LAVs for SARS-CoV-2, we engineered attenuated recombinant SARS-CoV-2 (rSARS-CoV-2) that simultaneously lacks the viral open reading frame 3a (ORF3a) in combination with either ORF6, ORF7a, or ORF7b (Δ3a/Δ6, Δ3a/Δ7a, and Δ3a/Δ7b, respectively) proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Disease Intervention and Prevention, and Population Health Programs, Texas Biomedical Research Institute, San Antonio, Texas, USA.
- Center for Vaccines and Immunity, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
- Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Center for Translational Antiviral Research, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA.
ORCID-Profile: Chengjin Ye, Luis Martinez-Sobrido
Förderung
- NIAID NIH HHS
- NIH HHS
Zitieren
APA
Ye, C., Park, J. G., Chiem, K., Dravid, P., Allué-Guardia, A., Garcia-Vilanova, A., Pino Tamayo, P., Shivanna, V., Kapoor, A., Walter, M. R., Kobie, J. J., Plemper, R. K., Torrelles, J. B., & Martinez-Sobrido, L. (2023). Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00653-23
Vancouver
Ye C, Park JG, Chiem K, Dravid P, Allué-Guardia A, Garcia-Vilanova A, et al. Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission. Microbiology Spectrum. 2023. doi:10.1128/spectrum.00653-23
BibTeX
@article{Ye2023,
author = {Ye, Chengjin and Park, Jun-Gyu and Chiem, Kevin and Dravid, Piyush and Allué-Guardia, Anna and Garcia-Vilanova, Andreu and Pino Tamayo, Paula and Shivanna, Vinay and Kapoor, Amit and Walter, Mark R and Kobie, James J and Plemper, Richard K and Torrelles, Jordi B and Martinez-Sobrido, Luis},
title = {Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission},
journal = {Microbiology Spectrum},
year = {2023},
doi = {10.1128/spectrum.00653-23}
}
EUVIMED